Eigen Therapeutics
Eigen Therapeutics is a biotechnology company focused on developing combination therapies to tackle tumor heterogeneity in cancer treatment. By utilizing a sophisticated platform that integrates machine learning, robotics, and high-throughput screening, Eigen aims to enhance the effectiveness of targeted therapies while minimizing side effects. Their innovative approach allows for better control of target levels in cancer cells, ultimately improving patient outcomes and expanding the eligibility for treatments. With a multidisciplinary team and a commitment to saving lives, Eigen is positioned to make significant advancements in the oncology space.
Eigen Therapeutics
Eigen Therapeutics is a biotechnology company focused on developing combination therapies to tackle tumor heterogeneity in cancer treatment. By utilizing a sophisticated platform that integrates machine learning, robotics, and high-throughput screening, Eigen aims to enhance the effectiveness of targeted therapies while minimizing side effects. Their innovative approach allows for better control of target levels in cancer cells, ultimately improving patient outcomes and expanding the eligibility for treatments. With a multidisciplinary team and a commitment to saving lives, Eigen is positioned to make significant advancements in the oncology space.